The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InLSV Asset Management has increased its ownership in biopharmaceutical giant Bristol Myers Squibb (NYSE:BMY) by 1.7%. The firm acquired an additional 138,119 shares, bringing its total holding to 8,269,472 shares. This strategic move positions BMY as LSV's 22nd largest holding, with an estimated value of $372.95 million. The increased stake follows Bristol Myers Squibb's recent Q4 earnings report, which saw an EPS of $1.26, a revenue beat of $12.5 billion, and a raised quarterly dividend to $0.63 per share. Despite the mixed earnings, LSV's action signals continued confidence in the pharmaceutical company.